A news feed tailored to your interests. One platform, trusted sources.
Free. Unsubscribe anytime.
Get your personalized news feed in three simple steps.
Life sciences, biotechnology, pharmaceuticals, venture capital, or deep tech—pick the areas you care about. Your feed is built only around what you select.
After you sign up, we build a single stream from trusted sources, updated daily. One place for all the topics you chose.
No noise, no ads. Just the news that’s relevant to you. Read from any device, in one place.
The most important daily developments and curated analysis from trusted sources.
One of the most ambitious regional initiatives in AI-powered biology to date has been launched in Seattle.
The year 2026 has become a defining moment for the biotechnology industry, not only because of new drug discoveries but also because of an unprecedented wave of large-scale acquisitions.
London-based Claret Capital Partners has closed its fourth growth debt fund at €575 million, exceeding its original target and reinforcing its position as one of Europe's largest independent growth debt managers.
Terra Industries, a Nigerian defense technology startup, added another $18 million to its seed funding round, bringing the total seed investment to $52 million.
The U.S.-based artificial intelligence startup Build has secured an $8.5 million seed investment for its platform, developed to automate due diligence processes used in infrastructure projects...
A personalized news experience, built for you.
A single stream tailored to your interests.
Life sciences, AI, startups, investments, and technology. Choose the topics you want to follow; all stories aggregated in one feed.
Carefully curated publications.
Curated stories from Nature, TechCrunch, Endpoints News, Fierce Biotech, and other trusted sources. Verified analysis instead of clickbait.
Valuable insights, zero clutter.
Stay on top of critical breakthroughs across deep tech, biotechnology, and venture capital in one unified place. Less noise, more insight.
One stream, built just for you. Trusted sources, ad-free experience, completely free.
Trusted sources
Carefully selected global publishers across biotechnology, life sciences, pharma, and venture capital. Verified insights instead of clickbait.
Always updated
A single stream refreshed throughout the day. Follow important developments without missing a beat.
Free, always
Access your personalized news feed completely free. No hidden fees or forced subscriptions.
Updates and product developments from Sightspace, curated content focused on digital assets and AI modules.